Background: We tested the cutaneous distribution of 50 chemicals in frozen human skin. The mass balance (MB) values for 48% of the chemicals were < 90%, possibly due to evaporation. Methods: We confirmed the reduction in MB was due to evaporation for two chemicals tested in skin penetration experiments using a carbon filter above the skin to trap airborne chemical. An in vitro assay was used to predict the reduction in MB due to evaporation by comparing the recovery of chemicals after 4 h of incubation at room temperature in open and closed vials. Results: Evaporative losses in vitro correlated well with measured MBs (i.e., < 90%) in skin penetration experiments (R2 = 0.81). There was a correlation of the MB with the vapour pressure (VP) which could be used to group chemicals according to their likelihood to evaporate during the course of a skin penetration study. There was also a correlation of MB with Henry’s law constants, melting and boiling points. Conclusion: Our data support the use of a quick and simple test for volatility to account for the loss of MB in skin penetration experiment due to volatility. The best parameter to indicate the potential of a chemical to evaporate is the VP.

1.
OECD
. Test No. 428: Skin Absorption: In Vitro Method.
2004
.
2.
OECD
: Test No. 28: Guidance Document for the Conduct of Skin Absorption Studies.
2004
.
3.
SCCS
: SCCS (Scientific Committee on Consumer Safety), basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients, 22 June 2010. (SCCS/1358/10)
2010
,
4.
Bucks
DA
,
McMaster
JR
,
Maibach
HI
,
Guy
RH
.
Bioavailability of topically administered steroids: a “mass balance” technique
.
J Invest Dermatol
.
1988
Jul
;
91
(
1
):
29
33
.
[PubMed]
0022-202X
5.
Frasch
HF
.
Dermal absorption of finite doses of volatile compounds
.
J Pharm Sci
.
2012
Jul
;
101
(
7
):
2616
9
.
[PubMed]
0022-3549
6.
Gilpin
SJ
,
Hui
X
,
Maibach
HI
:
Volatility of fragrance chemicals: patch testing implications.
Dermatitis : contact, atopic, occupational, drug
2009
;20:200-207.
7.
Steiner
A
,
Kugarajan
K
,
Wullimann
M
,
Ruty
B
,
Kunze
G
.
Margin of safety of pentylene glycol derived using measurements of cutaneous absorption and volatility
.
Regul Toxicol Pharmacol
.
2017
Jul
;
87
:
106
11
.
[PubMed]
0273-2300
8.
Hui
X
,
Wester
RC
,
Barbadillo
S
,
Cashmore
A
,
Maibach
HI
.
In vitro percutaneous absorption of benzene in human skin
.
Cutan Ocul Toxicol
.
2009
;
28
(
2
):
65
70
.
[PubMed]
1556-9527
9.
Gajjar
RM
,
Miller
MA
,
Kasting
GB
.
Evaporation of volatile organic compounds from human skin in vitro
.
Ann Occup Hyg
.
2013
Aug
;
57
(
7
):
853
65
.
[PubMed]
1475-3162
12.
Nangia
A
,
Patil
S
,
Berner
B
,
Boman
A
,
Maibach
H
:
In vitro measurement of transepidermal water loss: A rapid alternative to tritiated water permeation for assessing skin barrier functions.
1998
.
13.
Jacques-Jamin
C
,
Duplan
H
,
Rothe
H
,
Vaillant
O
,
Eilstein
J
,
Grégoire
S
, et al
Comparison of the Skin Penetration of 3 Metabolically Stable Chemicals Using Fresh and Frozen Human Skin
.
Skin Pharmacol Physiol
.
2017
;
30
(
5
):
234
45
.
[PubMed]
1660-5527
14.
SCCS
: SCCS (Scientific Committee on Consumer Safety), SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation 10th revision, 24-25 October 2018, SCCS/1602/18.
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.